
### [NCIT:C27632](http://purl.obolibrary.org/obo/NCIT_C27632)
**Label:** Transplant-Related Malignant Neoplasm

**Subclasses:** [NCIT:C27640](http://purl.obolibrary.org/obo/NCIT_C27640) (Transplant-Related Kaposi Sarcoma), [NCIT:C27695](http://purl.obolibrary.org/obo/NCIT_C27695) (EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder), [NCIT:C7249](http://purl.obolibrary.org/obo/NCIT_C7249) (Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7238](http://purl.obolibrary.org/obo/NCIT_C7238) (Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7237](http://purl.obolibrary.org/obo/NCIT_C7237) (Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7239](http://purl.obolibrary.org/obo/NCIT_C7239) (Hodgkin-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C7245](http://purl.obolibrary.org/obo/NCIT_C7245) (Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C27638](http://purl.obolibrary.org/obo/NCIT_C27638) (Transplant-Related Renal Cell Carcinoma), [NCIT:C7244](http://purl.obolibrary.org/obo/NCIT_C7244) (Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7233](http://purl.obolibrary.org/obo/NCIT_C7233) (Monomorphic Post-Transplant Lymphoproliferative Disorder), [NCIT:C27637](http://purl.obolibrary.org/obo/NCIT_C27637) (Transplant-Related Lung Carcinoma), [NCIT:C7247](http://purl.obolibrary.org/obo/NCIT_C7247) (Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C27639](http://purl.obolibrary.org/obo/NCIT_C27639) (Transplant-Related Hematologic Malignancy), [NCIT:C7246](http://purl.obolibrary.org/obo/NCIT_C7246) (Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7241](http://purl.obolibrary.org/obo/NCIT_C7241) (Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C27634](http://purl.obolibrary.org/obo/NCIT_C27634) (Transplant-Related Bladder Urothelial Carcinoma), [NCIT:C7240](http://purl.obolibrary.org/obo/NCIT_C7240) (Plasma Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C27633](http://purl.obolibrary.org/obo/NCIT_C27633) (Transplant-Related Carcinoma), [NCIT:C7243](http://purl.obolibrary.org/obo/NCIT_C7243) (Classical Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder), [NCIT:C27636](http://purl.obolibrary.org/obo/NCIT_C27636) (Transplant-Related Skin Squamous Cell Carcinoma), [NCIT:C7242](http://purl.obolibrary.org/obo/NCIT_C7242) (Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder), [NCIT:C27635](http://purl.obolibrary.org/obo/NCIT_C27635) (Transplant-Related Hepatocellular Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C81193](http://purl.obolibrary.org/obo/NCIT_C81193) (Immunosuppression-Related Post-Transplant Toxicity) 62.50%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 62.50%
- [NCIT:C36104](http://purl.obolibrary.org/obo/NCIT_C36104) (Aggressive Clinical Course) 62.50%
- Thing 51.30%
- [NCIT:C27955](http://purl.obolibrary.org/obo/NCIT_C27955) (Drug Toxicity) and [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) 47.86%
- [NCIT:C42607](http://purl.obolibrary.org/obo/NCIT_C42607) (Therapy-Related Toxicity) 41.37%
- [NCIT:C27955](http://purl.obolibrary.org/obo/NCIT_C27955) (Drug Toxicity) 41.37%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 40.58%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 39.85%
- [NCIT:C35461](http://purl.obolibrary.org/obo/NCIT_C35461) (Clinical Course of Disease) 37.31%
- [NCIT:C27990](http://purl.obolibrary.org/obo/NCIT_C27990) (Toxicity) 31.40%
- [NCIT:C3671](http://purl.obolibrary.org/obo/NCIT_C3671) (Injury) 26.93%
- [NCIT:C36291](http://purl.obolibrary.org/obo/NCIT_C36291) (Finding by Cause) 24.63%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 15.73%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 14.98%


